Plain-English translation of NCT06817174 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Researchers are testing a new computer-based method called radiomics that analyzes details in your CT scans that doctors cannot normally see with the naked eye. This approach may help predict how well you will respond to surgery and chemotherapy, and could help doctors personalize your treatment plan. The study involves 168 patients with advanced ovarian cancer who are planning to have surgery and chemotherapy.
Current treatment for ovarian cancer works differently for different patients, and doctors cannot always predict in advance who will benefit most from surgery first versus chemotherapy first. This new scan analysis method may reveal hidden information about your cancer that helps doctors choose the best treatment strategy for you individually.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will use your existing CT scan (which you would have anyway as part of standard cancer care) and analyze it using the new radiomics method. You will also share information about your cancer type and how you respond to surgery and chemotherapy as part of your normal treatment. There are no additional scans or medications required beyond your standard ovarian cancer care.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United Kingdom